Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)
China flag China · Delayed Price · Currency is CNY
5.98
-1.50 (-20.05%)
At close: Jun 11, 2026

SHA:688189 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,0392,1721,7842,5883,3834,931
Market Cap Growth
16.04%21.75%-31.04%-23.51%-31.39%-27.96%
Enterprise Value
1,6981,8271,4352,3703,4024,800
Last Close Price
7.487.976.549.4312.3317.97
Forward PE
-15.1615.1615.1615.1615.16
PS Ratio
16.0115.316.783.594.846.63
PB Ratio
2.943.052.032.012.613.54
P/TBV Ratio
3.003.132.252.222.904.04
P/FCF Ratio
-62.48-14.08--
P/OCF Ratio
607.6218.961280.4612.02--
EV/Sales Ratio
13.3312.885.453.294.876.46
EV/EBITDA Ratio
---58.91--
EV/EBIT Ratio
---546.78--
EV/FCF Ratio
-52.55-12.90--
Debt / Equity Ratio
0.010.010.250.250.420.34
Debt / EBITDA Ratio
---7.81--
Debt / FCF Ratio
-0.29-1.77--
Net Debt / Equity Ratio
-0.39-0.41-0.31-0.26-0.13-0.18
Net Debt / EBITDA Ratio
5.596.850.84-8.485.161.43
Net Debt / FCF Ratio
5.85-8.384.75-1.860.841.45
Asset Turnover
0.130.140.180.390.340.35
Inventory Turnover
2.022.002.834.242.671.94
Quick Ratio
3.533.692.052.882.252.27
Current Ratio
4.234.282.292.972.312.39
Return on Equity (ROE)
-20.00%-18.83%-36.72%-0.84%-7.26%-12.09%
Return on Assets (ROA)
-5.22%-4.81%-15.29%0.15%-2.44%-6.38%
Return on Invested Capital (ROIC)
-19.70%-15.22%-46.39%0.42%-7.03%-20.19%
Return on Capital Employed (ROCE)
-12.00%-10.90%-40.80%0.30%-6.10%-14.80%
Earnings Yield
-6.97%-6.30%-20.00%-0.42%-2.33%-3.28%
FCF Yield
-2.25%1.60%-3.20%7.10%-5.94%-3.58%
Buyback Yield / Dilution
-0.06%-0.00%0.03%-0.03%0.01%-6.66%
Total Shareholder Return
-0.06%-0.00%0.03%-0.03%0.01%-6.66%